Tag: statistics
-
Survey: Type-2 Diabetes Patients Would Switch from Insulin
A new survey shows 60 percent of type-2 diabetes patients in the U.S. who currently use insulin say they would prefer switching to a less expensive bio-similar insulin if such an agent became available. Decision Resources, a health care industry research firm, conducted the survey of diabetes patients in September 2010. Decision Resources reports most…
-
VCs Expect More Deals in 2011, but Not for Science
A survey of U.S. venture capital (VC) investors shows expectations of more investments for entrepreneurs in 2011 across all company stages from initial seed funding to later stage rounds. More VCs expect investments to increase in technology-related companies, however, rather than those based on scientific discoveries. The survey of 330 VC investors was conducted in…
-
Pharma R&D Q3 Output Keeps Pace, But Revenue Slides
The financial research company Fitch Ratings said in a report issued today that the global pharmaceutical companies followed by the company maintained a modest, but steady pace of new product approvals and regulatory filings to U.S., European, and Japanese regulators in the third quarter of 2010. The report, “Global Pharmaceutical R&D Pipeline: Third-Quarter 2010” (subscription…
-
Pharma Mergers Jump 20 Percent in 2010 [UPDATED]
Update: 12 January 2011. Life Science Analytics, the source of the statistics quoted in this entry, notes that the data refer to partnership deals, NOT mergers as the entry implies. The company asked that we post the following statement … Please note the reference to top deal makers in this article reflects their participation in…
-
More International Collaboration Found in Nanotech Research
Investigators at Georgia Institute of Technology in Atlanta and Florida International University (FIU) in Miami reveal how research in nanotechnology has increasingly become a multi-national enterprise, despite having some 60 countries now funding nanotech initiatives within their borders. Phillip Shapira of Georgia Tech and Jue Wang of FIU found nearly a quarter of all published…
-
Life Science Firms: FDA Improving but Still Not There
A survey of 50 life science companies conducted by the consulting firm PriceWaterhouseCoopers says the companies feel they have better working relationships with the U.S. Food and Drug Administration (FDA), but they say the agency still does not have adequate resources or is up to speed on advancing technology. The survey was sent electronically to…
-
Study: Youth Prescriptions Nearly Double Since 1994
Adolescents and young adults are most likely to abuse prescription medications, which after marijuana is their illicit drug of choice. Yet prescription rates for controlled medications have nearly doubled for those age groups in the past 14 years, according to a study published online in the journal Pediatrics. Overall, a controlled medication was prescribed for…
-
Report: U.S. Scientific Dominance Slipping
A study from Thomson Reuters, Global Research Report: United States, released today (12 November), found that research output from the United States has been surpassed by that of Asia and Europe. The report is based on an analysis of research papers in the most influential journals, as indexed by Thomson Reuters in the Web of…
-
Survey: U.K. Businesses Benefit from Academic Collaboration
Improving business performance is the main focus for companies collaborating with universities, rather than technological innovation, according to results of surveys of businesses and academic institutions released today. The surveys were conducted by the Centre for Business Research at the University of Cambridge in the U.K. and funded by the Economic and Social Research Council.…
-
Economic Model Computes Value of Workplace Flu Shots
Researchers from the University of Pittsburgh in Pennsylvania developed an economic model to calculate costs and benefits of employers providing flu vaccinations as an employee benefit. The team from the university’s Graduate School of Public Health showed employers can save substantial funds offering vaccinations, and the sooner in the flu season the shots are offered…